MedPath

Evaluation of the ReAura skin rejuvenation device for daily self-administred full face treatment of fine lines

Completed
Conditions
Huidveroudering
fine lines
Skin rejuvenation
Registration Number
NL-OMON35657
Lead Sponsor
Philips Research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
35
Inclusion Criteria

Age 30-65y, mild to moderate fine lines in the face

Exclusion Criteria

Decreased wound healing

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>> 60% of users >= 1 FWS improvement at 1 week follow-up (after 30 day treatment)</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Objective endpoints<br /><br>> 60% of users >= 1 FWS improvement after 2 month maintenance<br /><br>> 81% of users at least mild improvement in fine lines (quartile improvement<br /><br>scale)<br /><br>> 86% of users at least mild improvement in skin texture (quartile improvement<br /><br>scale)<br /><br>Subjective endpoints:<br /><br>> 70% of users at least mild improvement in fine lines<br /><br>> 83% of users at least mild improvement in skin texture<br /><br>> 86% of users at least mild improvement in overall appearance<br /><br>> 84% of users at least mild improvement in even skin tone</p><br>
© Copyright 2025. All Rights Reserved by MedPath